Article Details

Bio-Thera Solutions Announces Initiation of Phase I Clinical Trials for BAT6005, a ... - BioSpace

Retrieved on: 2021-12-29 18:50:47

Tags for this article:

Click the tags to see associated articles and topics

Bio-Thera Solutions Announces Initiation of Phase I Clinical Trials for BAT6005, a ... - BioSpace. View article details on hiswai:

Excerpt

... of Phase I Clinical Trials for BAT6005, a Monoclonal Antibody Targeting ... The CDR-H3 of our novel innovative antibodies is designed based on ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up